Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04520490 · ClinicalTrials.gov registry record · Phase 3

Brain Activation and Satiety in Children 2

A Phase 3 study of Childhood Obesity, sponsored by Seattle Children's Hospital.

Active
Registry status
Phase 3
Development phase
63
Enrollment target
1
Study location

NCT04520490 is a Phase 3 study of Childhood Obesity that is active but no longer recruiting, run by Seattle Children's Hospital. The registered enrollment target is 63 participants, below the 559-participant average among 43 other Childhood Obesity trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04520490, a Phase 3 study of Childhood Obesity, is active but no longer recruiting, sponsored by Seattle Children's Hospital.

ACTIVE NOT RECRUITING
Registry status
Phase 3
Development phase
63 participants
Enrollment target
1
Study location

Study Summary

Childhood obesity and related long-term effects are serious public health problems, but not all children with obesity do well in treatment. This study will test a new combination of family-based behavioral treatment (FBT) with a drug intervention using a glucagon-like peptide-1 receptor agonist (GLP-1RA) exenatide once weekly extended-release (ExQW, Bydureon®) in order to improve obesity intervention outcomes in 10-12-year-old children.

Conditions Studied

Interventions

  • DRUG Placebo
  • BEHAVIORAL Family Based Behavioral Treatment
  • DRUG Exenatide 2 mg [Bydureon]

Study Locations (1)

Washington

  • Seattle Children's Hospital - Seattle

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2021-01-28
Est. Completion 2026-02-12
Phase Phase 3

Sponsor

Seattle Children's Hospital

168 total trials

What the Registry Record Tells You About NCT04520490

The ClinicalTrials.gov registry entry for NCT04520490 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 559-participant average among 43 other Childhood Obesity trials with a reported enrollment target (89% lower). The listed sponsor is Seattle Children's Hospital, which has 168 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Childhood Obesity appearing as the primary indexed condition, and to 3 interventions - of which Placebo is the first listed.

NCT04520490 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT04520490 about?

NCT04520490 is a clinical study titled "Brain Activation and Satiety in Children 2". Childhood obesity and related long-term effects are serious public health problems, but not all children with obesity do well in treatment. This study will test a new combination of family-based behavioral treatment (FBT) with a drug intervention using a glucagon-like peptide-1 receptor agonist (GLP...

What is the current status of trial NCT04520490?

This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 63 participants. The study started on 2021-01-28. Estimated completion is 2026-02-12.

What conditions does trial NCT04520490 study?

This clinical trial studies the following conditions: Childhood Obesity.

What interventions are being tested in trial NCT04520490?

The interventions under investigation include: Placebo (DRUG), Family Based Behavioral Treatment (BEHAVIORAL), Exenatide 2 mg [Bydureon] (DRUG).

Who is sponsoring clinical trial NCT04520490?

This trial is sponsored by Seattle Children's Hospital, which has 168 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04520490 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Childhood Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.